CASI Pharmaceuticals (CASIF) Treasury Shares (2021 - 2025)
CASI Pharmaceuticals' (CASIF) quarterly Treasury Shares came in at $9.6 million in Q4 2025, little changed YoY from $9.6 million in Q4 2024, and up 200.0% on a QoQ basis from -$9.6 million in Q3 2025.
CASI Pharmaceuticals (CASIF) Treasury Shares (2021 - 2025) Analysis & Trends
CASI Pharmaceuticals (CASIF) has 5 years of Treasury Shares data on file, last reported at $9.6 million in Q4 2025.
- Quarterly Treasury Shares changed 0.0% year-over-year to $9.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.6 million (changed 0.0% YoY) and the FY2025 annual result came in at $9.6 million, changed 0.0% from the prior year.
- Treasury Shares climbed to $9.6 million in Q4 2025, from -$9.6 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $2.0 million in Q4 2024 to a low of $411952.0 in Q4 2023.
- A 5-year average of $925301.2 and a median of $617277.0 in 2021 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2024 — Treasury Shares changed 0.0% — and 2025, when it surged 99.9%.
- Tracing CASIF's Treasury Shares over 5 years: stood at $8.0 million in 2021, then rose by 16.13% to $9.3 million in 2022, then grew by 2.94% to $9.6 million in 2023, then changed by 0.0% to $9.6 million in 2024, then changed by 0.0% to $9.6 million in 2025.
- The last three Treasury Shares figures came in at $9.6 million (Q4 2025), -$9.6 million (Q3 2025), and -$9.6 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | CASI Pharmaceuticals | 2.65 Mn | -3.76 Bn | - | -9.60 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.00 Mn |
| Dec 31, 2025 | 9.60 Mn |
| Dec 31, 2025 | 9.60 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | -9.60 Mn |
| Sep 30, 2025 | -9.60 Mn |
| Jun 30, 2025 | -9.60 Mn |
| Jun 30, 2025 | -9.60 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Dec 31, 2024 | 9.60 Mn |
| Dec 31, 2024 | 9.60 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Jun 30, 2024 | -9.60 Bn |
| Jun 30, 2024 | -9.60 Bn |
| Mar 31, 2024 | -9.60 Mn |
| Mar 31, 2024 | -9.60 Mn |
| Dec 31, 2023 | 9.60 Mn |
| Dec 31, 2023 | 411,952.00 |
| Dec 31, 2023 | 9.60 Mn |
| Dec 31, 2023 | 411,952.00 |